Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128813) titled 'Research on Protein Metabolism Regulatory Networks in First-Episode Schizophrenia Patients with Suicidal Ideation' on July 27.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The Second General Hospital of Fuzhou Neuropsychiatric prevention and treatment Hospital
Condition:
First onset schizophrenia with suicidal ideation
Intervention:
case group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-30
Target Sample Size: case group:50;Healthy control group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr....